Reality TV star turned DJ, Jon Gosselin, made headlines earlier this year with his stunning weight loss transformation.

Jon Gosselin detailed the ebbs and flows of his weight-loss journey, which included semaglutide and weight gain, but he's ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans ...